. Author manuscript; available in PMC: 2011 Sep 1.

Published in final edited form as: Am Heart J. 2010 Sep;160(3):428–434. doi: 10.1016/j.ahj.2010.06.009

TABLE III.

LV Function and Volumes - BMC vs Placebo

	BMC (n=30)	Placebo (n=10)	P-Value
LVEF – LV-gram (%)	35.2 ± 8.4	36.5 ± 7.1	.494
Baseline LVEF (%)- ECHO	38.9 ± 10.9	37.4 ± 9.8	.331

Baseline LVEF (%)-cMRI	49.0 ± 9.5	48.6 ± 8.5	.731
Baseline LVEDV (ml/m²)	88 ±31	77 ± 12	.703
Baseline LVESV (ml/m²)	46 ± 26	40 ± 11	.894

Change in LVEF (%) from Baseline to 6 months	6.2 ± 9.8	9.4 ± 10.0	.425
Change in LVEDV (ml/m²) from Baseline to 6 months	−4 ± 22	17 ± 11	0.001
Change in LVESV (ml/m²) from Baseline to 6 months	−7 ± 3.3	−2 ± 8.4	.330

Data are expressed as mean ± SD.